A new £10 million scheme will give leading researchers and businesses the chance to work together to help those facing life-threatening conditions.
A new £10 million scheme will give leading researchers and businesses, based in the UK, the chance to work together to develop treatments and cures for those facing life-threatening conditions like cancer and dementia.
The UK is home to one of the strongest, most productive health and life sciences industries globally. The sector is worth £75 billion a year and employs 250,000 people across the UK.
The new Innovation Scholars Scheme, launched on 20 February by the Life Sciences Minister Nadhim Zahawi, will support secondments for academics to develop new technologies and techniques to help NHS patients as soon as possible.
The scheme offers investment to support collaboration in life sciences between researchers and industry.
It will include developing new healthcare wearable technologies such as smartwatches and monitors, diagnostic devices like mobile health units, and new personalised medicines based on patients’ genetic information.
The government also announced 6 new locations that have been awarded the prestigious designation of Life Science Opportunity Zone (LSOZ). These zones will be able to attract investment from national and international businesses linking research expertise with business skills.
Life Science Opportunity Zones
The government also announced 6 new locations that have been awarded the prestigious status of Life Science Opportunity Zone (LSOZ), helping raise their profile at a national and international level. These zones will be able to attract investment from national and international businesses linking research and business expertise.
These zones highlight the opportunities of the such as vacant lab space, land to build new facilities, or links with higher education. Their special designation will help them attract investment and deliver jobs, drive economic growth and deliver improved health based on the UK’s expertise in life sciences.
The new LSOZs are:
Researchers in the industry have already made huge advances in areas including early diagnosis, genomics, data, digital pathology and radiology, clinical research and manufacturing. These new zones will play a vital role in driving progress, economic growth and jobs and further supporting improving health outcomes.
Sourced by Department for Business, Energy & Industrial Strategy.